EuroPharma, Inc. – Trademark Portfolio
Entity Type: 03
EuroPharma, Inc. holds 60 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 58 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 4 Nice Classification classes. Currently, 32 trademarks are registered. Notable registered marks include VX1, BOS-10, BOSMED, ADAPTRA, and CURACEL. The owner is based in Green Bay, WI.
955 Challenger Drive
Green Bay, WI 54311
Showing of trademarks Trademarks
Trademark Classifications
EuroPharma, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does EuroPharma, Inc. have?
EuroPharma, Inc. has 60 U.S. trademarks filed with the USPTO. Of these, 32 registered, 15 abandoned, 13 cancelled.
What trademark classes does EuroPharma, Inc. file in?
EuroPharma, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 44 (Medical Services), Class 3 (Cosmetics & Cleaning), Class 41 (Education & Entertainment). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are EuroPharma, Inc.'s most well-known trademarks?
EuroPharma, Inc.'s registered trademark portfolio includes well-known marks such as VX1, BOS-10, BOSMED, ADAPTRA, and CURACEL. These are among 32 currently registered trademarks in the portfolio.
What is EuroPharma, Inc.'s trademark registration success rate?
EuroPharma, Inc. has a 53% trademark registration rate, with 32 out of 60 resolved applications resulting in successful registration. Currently, 0 applications are pending review.